Literature DB >> 16026940

Prevalence of fimbial colonization factors F18ab and F18ac in Escherichia coli isolates from weaned piglets with edema and/or diarrhea in China.

Darong Cheng1, Huaichang Sun, Jiansheng Xu, Song Gao.   

Abstract

F18ab and F18ac are important fimbrial colonization factors of verotoxigenic Escherichia coli (VTEC) and/or enterotoxigenic E. coli (ETEC) in weaned piglets with edema disease and/or diarrhea. To further investigate their prevalence and correlation to pathogenic E. coli, a duplex PCR, using three primers derived from the nucleotide sequence of the F18 major fimbrial subunit gene (fedA), and a direct agglutination test, using a monoclonal antibody specific for the antigenic factor 'a' of F18, were performed. Among 60VTEC, 24VTEC/ETEC and 24 ETEC isolates tested from weaned piglets with edema disease and/or diarrhea in different pig farms in the Jiangsu Province of China, 52 isolates (48.15%) were positive in the direct agglutination test and 63 isolates (58.33%) were positive in the duplex PCR. Among 63 PCR-positive isolates, 53 isolates (49.07%) were F18ab-positive and 10 isolates (9.26%) were F18ac-positive. In addition, the F18ab gene was more frequently detected in VTEC (61.67%) or VTEC/ETEC (62.50%) than in ETEC (4.17% only), while the F18ac gene was more frequently detected in VTEC/ETEC (33.33%) than in ETEC (8.33%) or VTEC (0%). Furthermore, F18ab was more frequently associated with Shiga toxin 2e (Stx2e), whereas F18ac was more frequently associated with enterotoxin ST I. These results suggest that the duplex PCR performed in this experiment is a more reliable method for identification of F18+E. coli, and that F18 is a more important virulence factor of VTEC and VTEC/ETEC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026940     DOI: 10.1016/j.vetmic.2005.06.006

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Prevalence and isoforms of the pathogenicity island ETT2 among Escherichia coli isolates from colibacillosis in pigs and mastitis in cows.

Authors:  DaRong Cheng; ShanYuan Zhu; ZhiRui Su; WeiYong Zuo; Hui Lu
Journal:  Curr Microbiol       Date:  2011-10-15       Impact factor: 2.188

2.  High prevalence of F4+ and F18+ Escherichia coli in Cuban piggeries as determined by serological survey.

Authors:  Pedro Yoelvys de la Fé Rodríguez; Annelies Coddens; Emanuele Del Fava; José Cortiñas Abrahantes; Ziv Shkedy; Luis O Maroto Martin; Eduardo Cruz Muñoz; Luc Duchateau; Eric Cox; Bruno Maria Goddeeris
Journal:  Trop Anim Health Prod       Date:  2011-01-14       Impact factor: 1.559

Review 3.  Initial adherence of EPEC, EHEC and VTEC to host cells.

Authors:  Marjorie Bardiau; Mihai Szalo; Jacques G Mainil
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

Review 4.  Pathogenomics of the virulence plasmids of Escherichia coli.

Authors:  Timothy J Johnson; Lisa K Nolan
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

5.  Histomorphometric characteristics of immune cells in small intestine of pigs perorally immunized with vaccine candidate F18ac nonenterotoxigenic E. coli strain.

Authors:  A Kovšca Janjatović; G Lacković; F Božić; D Spoljarić; M Popović; H Valpotić; N Vijtiuk; Z Pavičić; I Valpotić
Journal:  Eur J Histochem       Date:  2009-12-29       Impact factor: 3.188

6.  Expression of verocytotoxic Escherichia coli antigens in tobacco seeds and evaluation of gut immunity after oral administration in mouse model.

Authors:  Luciana Rossi; Alessia Di Giancamillo; Serena Reggi; Cinzia Domeneghini; Antonella Baldi; Vittorio Sala; Vittorio Dell'Orto; Annelies Coddens; Eric Cox; Corrado Fogher
Journal:  J Vet Sci       Date:  2013-06-28       Impact factor: 1.672

7.  Antimicrobial usage in pig production: Effects on Escherichia coli virulence profiles and antimicrobial resistance.

Authors:  Rukayya H Abubakar; Evelyn Madoroba; Oluwawemimo Adebowale; Olubunmi G Fasanmi; Folorunso O Fasina
Journal:  Onderstepoort J Vet Res       Date:  2019-10-31       Impact factor: 1.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.